Frontotemporal Dementia and Progressive Supranuclear Palsy

The W. Garfield Weston Foundation is pleased to announce the launch of the 2014 Targeted Diseases program in frontotemporal dementia and progressive supranuclear palsy this April.

• Goal: to provide targeted support for high impact, translational research in frontotemporal dementia and progressive supranuclear palsy.
• Funding: $50,000 to $150,000 per year over 1 to 3 years to a maximum of $450,000 per project
• Eligibility: the program is open to researchers at or above the level of postdoctoral fellow or equivalent from registered charitable institutions in Canada.